RA Capital Healthcare Fund LP 4
4 · Evommune, Inc. · Filed Feb 17, 2026
Research Summary
AI-generated summary of this filing
Evommune (EVMN) — RA Capital Management Receives $1.0M Equity Award
What Happened RA Capital Management, L.P. (the Adviser), an investment manager with a partner serving on Evommune’s board, reported an acquisition/award of 35,868 shares of Evommune (EVMN) on Feb 17, 2026. The shares were reported at $27.88 each, for a total value of $1,000,000. The transaction code is "A" (award/grant or other acquisition) — this is an acquisition of stock, not a sale.
Key Details
- Transaction date: 2026-02-17
- Shares acquired: 35,868 at $27.88 per share (total value $1,000,000)
- Transaction code: A (award/grant/other acquisition)
- Shares owned after transaction: not disclosed in the filing
- Footnotes: F1–F3 disclose that the Adviser is investment manager for RA Capital Healthcare Fund, L.P. and RA Capital Nexus Fund III, L.P.; the reported securities are held directly by those funds and various parties disclaim beneficial ownership except for pecuniary interest.
- Insider relationship: Dr. Derek DiRocco, a Partner of the Adviser, serves on Evommune’s board of directors (noted in Remarks).
- Filing timeliness: Reported for the same date as the transaction (no late filing indicated).
Context This filing reports an institutional acquisition by the Adviser on behalf of its funds, not a direct personal purchase by an individual executive. The filing’s footnotes emphasize the adviser/fund structure and disclaim broader beneficial ownership beyond pecuniary interest. The form does not state the purpose of the award (e.g., compensation vs. investment), and it does not show subsequent sales or transfers. For retail investors, purchases/awards by funds or adviser-affiliated entities can be informative, but the filing alone does not explain motivation.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-02-17$27.88/sh+35,868$1,000,000→ 2,710,293 total(indirect: See Footnotes)
- 784,345(indirect: See Footnotes)
Common Stock
[F1][F3]
Footnotes (3)
- [F1]RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
- [F2]Held directly by the Fund.
- [F3]Held directly by the Nexus Fund III.